CVR number 34093334
Industry 86.9090 Other human health activities

SKEJBY CRYOBANK ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.8% 0.8% 0.8% 0.8% 0.8%  
Bankruptcy risk  3.6% 11.8% 4.9% 4.9% 5.6%  
Credit score (0-100)  54 20 43 44 40  
Credit rating  BBB BB BBB BBB BBB  
Credit limit (kDKK)  0.0 -0.0 -0.0 -0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  3.4 -101 418 350 -48.8  
EBITDA  -85.1 -779 -438 -478 -371  
EBIT  -189 -782 -444 -486 -380  
Pre-tax profit (PTP)  -196.3 -782.3 -447.2 -499.9 -403.2  
Net earnings  -153.1 -610.1 -348.8 -498.3 -401.3  
Pre-tax profit without non-rec. items  -196 -782 -447 -500 -403  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.8 4.1 7.0 28.9 53.4  
Shareholders equity total  297 -313 -662 -1,161 -1,562  
Interest-bearing liabilities  1,591 2,452 3,094 3,710 4,336  
Balance sheet total (assets)  2,082 2,341 2,741 2,811 2,966  
Net Debt  1,578 2,436 3,014 3,582 4,061  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3.4 -101 418 350 -48.8  
Gross profit growth  -99.7% 0.0% 0.0% -16.3% 0.0%  
Employees  0 3 3 3 2  
Employee growth %  -100.0% 0.0% 0.0% 0.0% -33.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,082 2,341 2,741 2,811 2,966  
Balance sheet change%  -45.7% 12.4% 17.1% 2.5% 5.5%  
Added value  -85.1 -778.9 -438.0 -480.3 -371.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -208 -0 -3 14 16  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 -4.0 -5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -5,531.6% 772.8% -106.1% -138.8% 778.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -6.4% -33.0% -14.7% -13.2% -8.9%  
ROI %  -7.0% -36.0% -16.0% -14.3% -9.4%  
ROE %  -41.0% -46.3% -13.7% -17.9% -13.9%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  14.2% -11.8% -19.5% -29.2% -34.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -1,853.7% -312.8% -688.0% -748.7% -1,094.1%  
Gearing %  536.4% -782.3% -467.2% -319.7% -277.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.3% 0.0% 0.1% 0.4% 0.6%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.1 0.1 0.1 0.1  
Current Ratio  1.2 0.9 0.8 0.7 0.6  
Cash and cash equivalent  13.1 16.0 80.4 128.4 274.9  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  295.8 -317.6 -669.3 -1,189.4 -1,615.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 -260 -146 -160 -186  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 -260 -146 -159 -186  
EBIT / employee  0 -261 -148 -162 -190  
Net earnings / employee  0 -203 -116 -166 -201